Crossmark

18F-FET-PET as a biomarker for therapy response in non-contrast enhancing glioma following chemotherapy

Crossref DOI link: https://doi.org/10.1007/s11060-018-2919-0

Published Online: 2018-06-08

Published Print: 2018-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Suchorska, Bogdana https://orcid.org/0000-0002-1083-8232
Unterrainer, Marcus

Biczok, Annamaria

Sosnova, Marketa

Forbrig, Robert

Bartenstein, Peter

Tonn, Jörg-Christian

Albert, Nathalie Lisa

Kreth, Friedrich-Wilhelm
License Information

Text and Data Mining valid from 2018-06-08
More Information

Article History

Received: 18 February 2018

Accepted: 31 May 2018

First Online: 8 June 2018

Compliance with ethical standards

:

: Bogdana Suchorska, Marcus Unterrainer, Annamaria Biczok, Marketa Sosnova, Robert Forbrig, Peter Bartenstein, Nathalie Lisa Albert, Friedrich-Wilhelm Kreth reports that they have no conflict of interest. Jörg-Christian Tonn has received honoraria for advisory board participation from Celldex, Roche, BrainLab, and Siemens.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.